Search Results 411-420 of 23878 for prostate cancer
Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.
... prostate cancer is greater than 95 percent. Given that the majority of men who undergo prostatectomy for prostate cancer will not die from their disease, we ...
After confirming a prostate cancer diagnosis, the healthcare team might use MRI to see whether the cancer has grown beyond the prostate. This information helps ...
The goal of this study is to improve detection of prostate cancers that require treatment. Achieving the aims of this research will lead to better care and ...
... cancer derived microparticles in the serum of men that practice a daily intermittent fasting regimen after treatment for localized, high-risk prostate cancer.
... prostate cancer. Aug. 20, 2025. Since 2022, lutetium Lu 177 vipivotide tetraxetan has been used to treat prostate-specific membrane antigen (PSMA)-positive ...
Prostate cancer: Does PSA level affect prognosis? Prostate-specific antigen (PSA) is a protein made by prostate tissue. Men with prostate cancer often have ...
Changes in sperm and semen that may affect having children, called infertility. There's no proof that prostatitis can lead to prostate cancer. Researchers are ...
Unfortunately, most men in this situation will go on to develop metastatic castration-resistant prostate cancer (mCRPC) and require secondary systemic therapy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.